| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.052 | 0.8 |